1. Home
  2. NEUP vs INVH Comparison

NEUP vs INVH Comparison

Compare NEUP & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • INVH
  • Stock Information
  • Founded
  • NEUP 1996
  • INVH 2012
  • Country
  • NEUP United States
  • INVH United States
  • Employees
  • NEUP N/A
  • INVH N/A
  • Industry
  • NEUP
  • INVH Real Estate
  • Sector
  • NEUP
  • INVH Finance
  • Exchange
  • NEUP Nasdaq
  • INVH Nasdaq
  • Market Cap
  • NEUP 17.4B
  • INVH 19.1B
  • IPO Year
  • NEUP N/A
  • INVH 2017
  • Fundamental
  • Price
  • NEUP $4.88
  • INVH $31.92
  • Analyst Decision
  • NEUP Strong Buy
  • INVH Buy
  • Analyst Count
  • NEUP 1
  • INVH 17
  • Target Price
  • NEUP $21.00
  • INVH $37.88
  • AVG Volume (30 Days)
  • NEUP 1.6M
  • INVH 2.4M
  • Earning Date
  • NEUP 02-14-2025
  • INVH 02-26-2025
  • Dividend Yield
  • NEUP N/A
  • INVH 3.64%
  • EPS Growth
  • NEUP N/A
  • INVH N/A
  • EPS
  • NEUP N/A
  • INVH 0.72
  • Revenue
  • NEUP $662,715.00
  • INVH $2,554,563,000.00
  • Revenue This Year
  • NEUP N/A
  • INVH N/A
  • Revenue Next Year
  • NEUP N/A
  • INVH $4.25
  • P/E Ratio
  • NEUP N/A
  • INVH $44.43
  • Revenue Growth
  • NEUP N/A
  • INVH 7.65
  • 52 Week Low
  • NEUP $2.12
  • INVH $30.13
  • 52 Week High
  • NEUP $15.72
  • INVH $37.80
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • INVH 54.86
  • Support Level
  • NEUP N/A
  • INVH $31.32
  • Resistance Level
  • NEUP N/A
  • INVH $32.31
  • Average True Range (ATR)
  • NEUP 0.00
  • INVH 0.54
  • MACD
  • NEUP 0.00
  • INVH 0.11
  • Stochastic Oscillator
  • NEUP 0.00
  • INVH 76.90

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of nearly 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.

Share on Social Networks: